Extensive research and multiple meta-analyses have explored the multifaceted roles of the chemokine receptor CXCR4 in non-small cell lung cancer (NSCLC), identifying it as a key player in several tumor-promoting processes [40,41]. The gene discussed is CXCR4; the disease is neoplasm.